New study aims to keep macular disease patients on track with eye injections
NCT ID NCT07567898
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a personalized care approach helps patients with chronic macular diseases (like wet age-related macular degeneration and diabetic macular edema) attend their regular eye injection appointments. Many patients skip these vital treatments, risking further vision loss. The study will enroll 200 participants at the Singapore National Eye Centre, randomly assigning some to receive a tailored plan involving consultations with nurses, optometrists, and social workers, while others receive standard care. The goal is to see if the personalized plan improves adherence to treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could eye drops replace injections for a leading cause of blindness?
- Could a daily eye gel replace injections for wet AMD?
- Can a new eye injection preserve vision in south asians with diabetes?
- Could a biosimilar eye injection offer a new way to treat diabetic macular edema?
- Can a steroid implant boost the effect of standard eye injections for hard-to-treat diabetic macular edema?
- Eye injection aims to tame leading causes of blindness